DrugPatentWatch Database Preview

Details for Patent: 8,778,997

Which drugs does patent 8,778,997 protect, and when does it expire?

Patent 8,778,997 protects RAPIVAB and is included in one NDA.

This patent has twenty-seven patent family members in thirteen countries.

Summary for Patent: 8,778,997

Title:	Antiviral treatments
Abstract:	The invention provides unit dosage forms, kits, and methods useful for treating viral infections.
Inventor(s):	Babu; Yarlagadda Sudhakara (Birmingham, AL), Chand; Pooran (Birmingham, AL), Bantia; Shanta (Birmingham, AL), Arnold; Shane (Hoover, AL), Kilpatrick; John Michael (Helena, AL)
Assignee:	BioCryst Pharmaceuticals, Inc. (Birmingham, AL)
Application Number:	13/103,562
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,778,997

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Biocryst	RAPIVAB	peramivir	SOLUTION;IV (INFUSION)	206426-001	Dec 19, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN ADULTS	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,778,997

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,770,427	Antiviral treatments	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,778,997

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Mexico	2008013140	➤ Sign Up
Mexico	2008010394	➤ Sign Up
South Korea	20160129105	➤ Sign Up
South Korea	20140132778	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,778,997

For more information try a trial or see the plans and pricing